Data / Medical devices / United States / Merz North America, Inc.
Merz North America, Inc.: FDA-registered device maker in Sturtevant, WI, United States, 15 510(k) clearances and 6 PMA approvals
Merz North America, Inc. is registered with the FDA (registration 3013840437) in Sturtevant, WI, United States. It lists 15 device types. The FDA files 15 510(k) clearances and 6 PMA approvals under its listings, the newest dated July 9, 2026. Registered through 2027. FDA data exported November 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3013840437
- Address
- 13900 W. Grandview Parkway, Sturtevant, WI, United States, 53177
- Owner or operator
- Merz North America, Inc. (9043404)
- Roles
- Complaint file establishment, Manufacturer, Repackager or relabeler, Specification developer
- First device listed
- August 5, 2003
- Registered through
- 2027
- Brand names listed
- Accessory Kit, Belotero Balance (+) Lidocaine Dermal Filler, Belotero Balance Dermal Filler, Belotero Intense (+) Lidocaine, Belotero Volume (+) Lidocaine, CSH Cannula; STERiGLIDE, Cellfina System Prep Pack - CP1, Coaptite Injectable Implant and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| May 21, 2026 | K260618 | Ulthera® System | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| May 13, 2025 | K250418 | Ulthera System (UC-1 Control Unit PRIME Model 2.1) | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| February 24, 2025 | K243035 | Ulthera® System | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| February 22, 2024 | K233996 | Ulthera System (UC-1 Control Unit PRIME) | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| May 4, 2018 | K180623 | Ulthera System | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| November 29, 2017 | K172689 | DESCRIBE PFD Patch | PKO | Substantially Equivalent | Merz North America, Inc. | accessdata.fda.gov |
| October 5, 2016 | K161885 | The Cellfina System | OUP | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| July 29, 2015 | K150505 | Cellfina System | OUP | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| June 20, 2014 | K134032 | ULTHERA SYSTEM | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| December 11, 2013 | K132028 | ULTHERA SYSTEM | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| October 2, 2012 | K121700 | ULTHERA SYSTEM | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| August 28, 2012 | K122528 | ULTHERA SYSTEM | OHV | Substantially Equivalent | Ulthera, Inc. | accessdata.fda.gov |
| September 11, 2009 | DEN080006 | ULTHERA SYSTEM, MODEL 8850-0001 | OHV | Unknown | Ulthera, Inc. | accessdata.fda.gov |
| April 18, 2006 | K060815 | JULIESSE INJECTABLE LARYNGEAL AUGMENTATION IMPLANT | MIX | Substantially Equivalent | Bioform Medical, Inc. | accessdata.fda.gov |
| January 9, 2002 | K013243 | COAPTITE LARYNGEAL AUGMENTATION SYSTEM 1CC & O.5CC, MODELS 0008021-1, 0008022-1 | KHJ | Substantially Equivalent | Bioform, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| July 9, 2026 | P250016 | Belotero® Intense (+) Lidocaine | LMH | 4 | October 21, 2026 | accessdata.fda.gov |
| May 19, 2026 | P250020 | Belotero Volume (+) Lidocaine | LMH | 4 | September 10, 2026 | accessdata.fda.gov |
| November 14, 2011 | P090016 | BELOTERO BALANCE | LMH | 60 | May 3, 2026 | accessdata.fda.gov |
| December 22, 2006 | P050052 | RADIESSE INJECTABLE IMPLANT | LMH | 169 | June 26, 2026 | accessdata.fda.gov |
| December 22, 2006 | P050037 | RADIESSE 1.3CC AND 0.3CC | LMH | 147 | June 26, 2026 | accessdata.fda.gov |
| November 10, 2005 | P040047 | COAPTITE | LNM | 76 | June 26, 2026 | accessdata.fda.gov |
Compare with other makers
- All makers of Agent, Bulking, Injectable For Gastro-Urology Use
- All makers of Instrument, Ent Manual Surgical
- All makers of System, Imaging, Pulsed Echo, Ultrasonic
- All makers of Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption
- All makers of Polymer, Ent Synthetic-Polyamide (Mesh Or Foil Material)
- All makers of Kit, Surgical Instrument, Disposable
Updated October 21, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.